How can we ensure that all communities are represented in Alzheimer’s and related dementias research and have access to the latest treatments and interventions? Dr. Carl Hill, the chief diversity, equity and inclusion (DEI) officer for the Alzheimer's Association, joins the podcast to delve into the significance of representation, diversity, equity, equality and inclusion within Alzheimer's disease research. He discusses the challenges of underrepresentation in clinical trials, the importance of community-based participatory research (CBPR) and the social determinants of health that influence Alzheimer's risk.
Guest: Carl V. Hill, PhD, MPH, chief diversity, equity and inclusion officer, Alzheimer's Association
Show NotesLearn more about the Alzheimer’s Association’s effort in DEI from their inaugural DEI report.
Learn more about race-related topics in Alzheimer’s disease from the Alzheimer’s Association International Conference (AAIC) 2022 here, including a study on the impact of racism on the brain and findings on racial disparities in health equity and resources in Black and Brown communities.
Listen to Dr. Hill’s past episodes of Dementia Matters, “Scientific Importance Of Diversity In Alzheimer’s Disease Research,” and, “Battling Health Disparities In Aging Research And Care,” on our website.
Learn more about Dr. Hill in his bio on the Alzheimer’s Association’s website.
Connect with usFind transcripts and more at our website.
Email Dementia Matters: dementiamatters@medicine.wisc.edu
Follow us on Facebook and Twitter.
Subscribe to the Wisconsin Alzheimer’s Disease Research Center’s e-newsletter.
Making an IMPACT: Advancing Alzheimer’s Disease Clinical Trials Through Workforce Development and Inclusivity
Living with Lewy Body: A Neurologist’s Journey Through Research and Dementia Care
The Fundamentals of Neuropsychology: Breaking Down Cognition, Memory and More
Long COVID and Its Effect on Cognition
Listen Up! The Connections Between Hearing Loss, Hearing Interventions and Cognitive Decline
From Caregiver to Research Participant: How One Woman’s Experience as a Dementia Caregiver Drew Her to Alzheimer’s Research
Looking at Lecanemab’s Eligibility Guidelines and Prescription Process
Do Non-Medicinal Interventions Reduce Dementia Risk? Studies are Inconclusive, Here’s Why
The Road to Hope: Philanthropy’s Impact on Alzheimer’s Research
Could Green Tea Hold the Key to New Alzheimer’s Treatments?
The Impact of Social Isolation on Dementia Risk in Older Adults
Memories and Milestones: Celebrating Six Years of ‘Dementia Matters’
Crosswords or Computers: Which is Better for Cognitive Engagement?
RAISE(ing) Support for Caregivers: State and National Resources for Family Care Partners
Mental Health and Memory: The Connections between Chronic Mental Illness and Dementia
Highlights from the 2023 Alzheimer’s Association International Conference
Agitation and Alzheimer’s: Strategies for Managing Behavioral and Psychological Symptoms of Dementia
Promises to Practice: Creating Sustainable Community Partnerships to Support Alzheimer’s Research
Study Shows APOE Gene Affects Hispanic Populations’ Risk of Cognitive Decline Differently to Non-Hispanic Populations
Create your
podcast in
minutes
It is Free
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks